Status:
UNKNOWN
Clinical Value of Left Colic Artery in Laparoscopic Radical Rectectomy
Lead Sponsor:
Shanghai Minimally Invasive Surgery Center
Conditions:
Overall Survival
Postoperative Complications
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Colorectal cancer is one of the most common tumors in Asia. According to the recent research, surgical procedure could provide more treatment benefit in rectal cancer. Therefore, it was consider that ...
Eligibility Criteria
Inclusion
- Aged more then 18 years old;
- Diagnosed as rectal cancer with colonoscopic biopsy;
- Without metastasis;
- No Invasion of surrounding tissues;
- Limited operation;
- Underwent laparoscopic radical proctectomy(L-Dixon);
- BMI 18\~30kg/m2;
- Without multiple primary tumors;
- Sign on the Medical informed Consent.
Exclusion
- Simultaneous or simultaneous multiple primary colorectal cancer;
- Preoperative imaging examination results show: (1) Tumor involves the surrounding organs and combined organ resection need to be done; (2)distant metastasis; (3)unable to perform R0 resection;
- History of any other malignant tumor in recent 5 years;
- Patients need emergency operation;
- Not suitable for laparoscopic surgery;
- Women during Pregnancy or breast feeding period;
- Informed consent refusal
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT03349788
Start Date
January 1 2018
End Date
January 1 2022
Last Update
December 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Ruijin Hospttal
Shanghai, Sahgnhai, China, 200000